跳至主要内容
临床试验/TCTR20180222002
TCTR20180222002尚未招募4 期

The Pharmacokinetic/Pharmacodynamic Study of Biapenem combination with Fosfomycin sodium against Acinetobacter baumannii infection in Thai Critically Ill

Faculty of Graduate Studies, Mahidol University0 个研究点目标入组 20 人开始时间: 2018年2月22日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Critically ill patients who (i) suspected Gram negative bacteria infection (ii) will prescribe iv. biapenem and fosfomycin sodium by the treating physician
  • The severity of illness of each patient describe by using the acute physiology and chronic health evaluation II (APACHE II) more than 15 and sequential organ failure assessment (SOFA) scores more than 2 on day 1 of treatment.

排除标准

  • Patients meeting any of the following criteria will be excluded: (i) age less than 18 years, (ii) contraindication with biapenem, (iii) history of biapenem hypersensitivity (iv) pregnancy or lactation, and (v) consent not obtained.

研究者

发起方
Faculty of Graduate Studies, Mahidol University

相似试验